ESE COVID-19 Research Grant

The COVID-19 pandemic is associated with a highly variable presentation, ranging from patients who are asymptomatic or experience only mild symptoms to others with acute respiratory syndrome who require ventilatory support and carry a high risk of severe adverse outcomes and mortality. Age, male sex and presence of comorbidities including, diabetes and coronary heart disease have been consistently identified as factors associated with poor prognosis.

It remains uncertain whether specific mechanisms related to endocrine or metabolic pathways result in variable outcome of COVID-19 infections. Likewise, it is unknown whether any underlying interaction between viral infection and the endocrine system could be used for the identification of predictive biomarkers or the development of therapeutic avenues.

The European Society of Endocrinology recognises the challenges faced by the endocrine community during the COVID-19 pandemic. While large research programs – particularly in the development of diagnostic tests and vaccines – have been put forward, specific funding of endocrine or metabolic aspects of the disease are lacking.

The ESE COVID-19 Research Grant has been developed to provide financial support for individuals to address scientific questions in COVID-19 research that relate to endocrinology and metabolism.


What is the Grant?

The Grant aims to provide financial support for a specific scientific project that engages in research in the context of COVID-19 infection and endocrinology or metabolism. Examples include the following topics, while other research questions might apply as well:

  • Characterisation of hormonal or metabolic markers that identify populations at risk for severe (or mild) COVID-19 disease
  • Investigation of hormonal related mechanisms of disease
  • Investigation of COVID-19 related short and long term consequences on endocrine function
  • Research on endocrine related therapies in the context of COVID-19 disease
  • Investigation of the burden of disease for patients with endocrine conditions

One grant of € 20 000, with a deadline of application of 30 June 2020 will be made available to individual researchers. In rare circumstances the grant may be split.

The Grant will be made available to use for consumables, supporting administration, meetings, data collection or processing, salary or third-party assistance.


How to Apply 

  • The Grant is available by application only.
  • Applications are made through an online form available on the ESE website.
  • Applications which are incomplete or deemed not to have provided the required information will not be considered.
  • Applications not received within the stated deadlines will not be considered

Please note: It is the institution and not the individual researcher that receives the grant. Overheads are not eligible.


Grant Eligibility

The Grant is open to application from (all criteria essential):

  • Lead applicant as an ESE member (valid membership for the year of application)
  • Employee(s) of universities/other public-sector research institutions
  • Proposed projects that are conducted primarily in Europe
  • Projects which are not in conflict with the European Society of Endocrinology’s major goals

General application requirements

  • The applicant must meet the grant eligibility criteria
  • Applications must be written in English.

Grant size

  • The maximum size of the grant is € 20 000, as stated above
  • The grant may be received in addition to other grants provided that this does not conflict with the other grant’s conditions
  • Financial support must be used for the stated purpose

Eligible expenses 

Successful applicants are eligible to apply for funding to cover:

  • Relevant and necessary salary expenses
  • Consumables related to the working programme
  • Per diem expenses for the applicant organization’s staff
  • Supporting administration
  • Data collection or processing
  • Third-party assistance

The above costs must relate directly to the research grant application.


  • Funding applications cannot be accepted for expenses already funded by another public-sector fund


  • A synopsis of outcomes or progress report will be expected within a year of the award
  • Awardees may be asked to present their findings at an ESE meeting in person
  • Funding from ESE must be acknowledged within publications and presentations



  • The European Society of Endocrinology is responsible for establishing a Jury for the Grant
  • The Jury will consist of the ESE Science Committee Members, plus any additional expertise from within the Society as required. Potential conflicts of interest of Jury members will need to be declared and decided on
  • The Chair of the Jury will be the Chair of the ESE Science Committee
  • The decision of the Jury will be final

Jury process:

  • Applications will be collated and submitted for review by the Jury
  • Application will be considered for eligibility and scientific credibility by the Jury
  • Applications will be ranked by the Jury based on the expected scientific impact for the Endocrine community
  • Collated rankings will be used to determine successful applications
  • In the event of equal ranking of two or more applications, the application led by the more junior applicant will be chosen
  • The applicant(s) will be informed of the outcome no later than 31 July 2020

Applications will be evaluated according to the following criteria:

  • The applicant has described the concept of the research project in explicit and concrete terms (purpose and content)
  • Projects must address research relating to endocrinology and COVID-19
  • Projects must be of clear direct benefit to the endocrine community.
  • Cross-European collaboration is strongly encouraged

The evaluation criteria form the basis for ESE’s evaluation of applications and its grant-award decision.

As this is a competitive call for funding applications, fulfilment of the criteria is no guarantee that funding will be awarded.

Subscribe to our email alerts